Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]      
Revenues
Operating Expenses:      
Research and development 8,596,898 6,562,925 2,936,252
General and administrative 6,285,480 6,446,517 6,063,439
Stock-based compensation – general and administrative 715,983 779,701 986,620
Total Operating Expenses 15,598,361 13,789,143 9,986,311
Operating Loss (15,598,361) (13,789,143) (9,986,311)
Other Income (Expense), Net:      
Interest income 52,660
Gain on extinguishment of liability 450,000
Other income 818,343
Gain on revaluation of derivative warrant liability 452,147
Interest expense (16,443) (15,838) (850,789)
Total Other Income (Expense), Net 36,217 1,252,505 (398,642)
Loss before Income Taxes (15,562,144) (12,536,638) (10,384,953)
Income tax benefit
Net Loss $ (15,562,144) $ (12,536,638) $ (10,384,953)
Net Loss Per Share - Basic and Diluted $ (0.77) $ (1.17) $ (1.89)
Weighted Average Common Shares Outstanding      
Basic and diluted 20,161,854 10,731,875 5,482,494